Hemophilia Alliance Newsletters

Advocacy Update, October 2026

Advocacy and Legal Updates

Medicaid Changes Start to Take Effect
by Artemis Policy Group

As previously reported, a federal law enacted in 2025 (H.R. 1, originally called the One Big Beautiful Bill Act) is starting to dramatically reshape the Medicaid program. On October 1, 2026, new policies went into effect ending eligibility for federally-funded Medicaid and CHIP coverage for certain groups of lawfully present immigrants. (See KFF table reprinted below; for information on state-funded Medicaid and CHIP programs that continue to provide coverage for certain groups of lawfully present immigrants, see this additional KFF resource.) HTCs should note that in families with blended immigration statuses, family members who are U.S. citizens remain eligible for Medicaid/CHIP coverage.

Other major changes to Medicaid eligibility are coming for HTC patients and millions of other Americans when H.R. 1’s “community engagement” [work] requirements go into effect for adults covered under the Medicaid expansion pathway. The Hemophilia Alliance, working with national bleeding disorders partners, has created a toolkit that we hope will help HTCs, chapters, and member organizations understand and explain Medicaid work requirements to the patient communities you serve. The toolkit includes both a comprehensive overview of the new requirements and individual pages or sections that you may wish to use in your communications with patients.

Alliance Hill Day

The Hemophilia Alliance held its 15th Hill Day on September 29, 2026. Participating advocates included patients and families living with bleeding disorders; hemophilia treatment center (HTC) staff; and representatives from the National Bleeding Disorders Foundation, Hemophilia Federation of America, and the Coalition for Hemophilia B – in all, 132 people from 35 states! The group visited 160 offices across Capitol Hill to educate lawmakers about bleeding disorders and policies important to the bleeding disorder community:

  • The importance of the federal hemophilia programs at HRSA and CDC.
  • The need to maintain HTCs’ ability to participate in the 340B program, and to avoid one-size-fits-all reforms that ignore the unique characteristics of HTC 340Bs.
  • Ending copay accumulators, maximizers, and other insurer practices that make it hard for patients to afford their medicines and stay on therapy.


The Hemophilia Alliance thanks all the individuals and groups who participated in this year’s Alliance Hill Day. Our unified voice helps lift up policies that will benefit all people living with bleeding disorders!

Have a story you want to share or a topic you would like us to cover?

Also In This Issue…
Jeff Weighs In
Alliance Update
  • We Have Moved!
  • The Hemophilia Alliance Welcomes New Team Members!
Member and Community Relations Update
  • Open Enrollment Is Here: Helping Patients Protect Access to Hemophilia Care
  • Why U.S. Health Insurance Feels So Complicated and What It Means for Hemophilia Treatment Centers
Administration and Operations Update
  • Member Feedback Helping Shape Alliance Priorities
  • A Spooktacular Fall Member Meeting: Connections, Collaboration & Community
  • Speaker Spotlight, Upcoming 29th Annual Linda Gammage Social Worker Conference
Notes From The Community
  • What Is a 340B Program and Why Does It Matter for People with Bleeding Disorders?

Team Alliance Contact Information

We work for you! Please don’t hesitate to contact any of us with any questions or concerns:

Name Email Phone
Jeff Blake jeff@hemoalliance.org 317-657-5913
Jennifer Borrillo, MSW, LCSW, MBA borrillo@hemoalliance.org 504-376-5282
Heidi Lane, PT, DPT, PCS heidi@hemoalliance.org 435-659-1230
Theresa Bello, PharmD, Rph bello@hemoalliance.org 732-674-0176
Angela Blue, MBA angela@hemoalliance.org 651-308-3902
Karen Bowe-Hause, MBA, MT karen@hemoalliance.org 717-571-0266
Jazzmine Brown, MBA, MSW, LCSW jazzmine@hemoalliance.org 770-570-2649
Ashley Castello, MEd ashley@hemoalliance.org 225-266-5062
Zack Duffy zack@hemoalliance.org 503-804-2581
Michael B. Glomb MGlomb@ftlf.com 202-466-8960
Miriam Goldstein mgoldstein@artemispolicygroup.com 703-304-8111
Johanna Gray, MPA jgray@artemispolicygroup.com 703-304-8111
Kiet Huynh kiet@hemoalliance.org 917-362-1382
Elizabeth Karan elizabeth@karanlegalgroup.com 612-202-3240
Kollet Koulianos, MBA kollet@hemoalliance.org 309-397-8431
Roland P. Lamy, Jr. roland@hemoalliance.org 603-491-0853
Danisha Nicolas, MPH danisha@hemoalliance.org 305-399-3974
Dr. George L. Oestreich, Pharm.D., MPA george@gloetal.com 573-230-7075
Nyla Page nyla@hemoalliance.org 603-986-0733
Theresa Parker theresa@hemoalliance.org 727-688-2568
Jennifer Anders Rose rose@hemoalliance.org 954-218-8509
Kelly Waters, MSW, LCSW kelly@hemoalliance.org 804-317-4998